Platelet Transfusion Practices in the ICU: Data From a Large Transfusion Registry

Chest

Volumn 150, Issue 3, 2016, Pages 516-523

  Ning, Shuoyan ^a   Barty, Rebecca ^a   Liu, Yang ^a   Heddle, Nancy M ^a   Rochwerg, Bram ^a   Arnold, Donald M ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b CANADIAN BLOOD SERVICES   (Canada)

Author keywords

ICU; platelet; thrombocytopenia; transfusion

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD GROUP ABO INCOMPATIBILITY; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; CRYOPRECIPITATE; ERYTHROCYTE TRANSFUSION; FEMALE; HEALTH CARE PRACTICE; HEART SURGERY; HUMAN; INTENSIVE CARE UNIT; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; BLOOD COMPONENT THERAPY; BLOOD GROUP INCOMPATIBILITY; CANADA; HEMORRHAGE; LIVER DISEASES; MIDDLE AGED; PROCEDURES; REGISTER; SURGERY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

AGED; BLOOD COMPONENT TRANSFUSION; BLOOD GROUP INCOMPATIBILITY; CANADA; ERYTHROCYTE TRANSFUSION; FEMALE; HEMORRHAGE; HUMANS; INTENSIVE CARE UNITS; LIVER DISEASES; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PLATELET TRANSFUSION; REGISTRIES; RETROSPECTIVE STUDIES; SEPSIS; SURGICAL PROCEDURES, OPERATIVE; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 84995554804     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2016.04.004     Document Type: Article

References (56)

1. 1 Hui, P., Cook, D.J., Lim, W., Fraser, G.A., Arnold, D.M., The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest 139:2 (2011), 271–278.
2. 2 Williamson, D.R., Albert, M., Heels-Ansdell, D., et al. Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes. Chest 144:4 (2013), 1207–1215.
3. 3 Lauzier, F., Arnold, D.M., Rabbat, C., et al. Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis. Intensive Care Medicine 39:12 (2013), 2135–2143.
4. 4 Stanworth, S.J., Walsh, T.S., Prescott, R.J., et al. Thrombocytopenia and platelet transfusion in UK critical care: a multicenter observational study. Transfusion 53:5 (2013), 1050–1058.
5. 5 Strauss, R., Wehler, M., Mehler, K., Kreutzer, D., Koebnick, C., Hahn, E.G., Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med 30:8 (2002), 1765–1771.
6. 6 Brogly, N., Devos, P., Boussekey, N., Georges, H., Chiche, A., Leroy, O., Impact of thrombocytopenia on outcome of patients admitted to ICU for severe community-acquired pneumonia. J Infect 55:2 (2007), 136–140.
7. 7 Vandijck, D.M., Blot, S.I., De Waele, J.J., Hoste, E.A., Vandewoude, K.H., Decruyenaere, J.M., Thrombocytopenia and outcome in critically ill patients with bloodstream infection. Heart Lung 39:1 (2010), 21–26.
8. 8 Lieberman, L., Bercovitz, R.S., Sholapur, N.S., Heddle, N.M., Stanworth, S.J., Arnold, D.M., Platelet transfusions for critically ill patients with thrombocytopenia. Blood 123:8 (2014), 1146–1151 quiz 1280.
9. 9 Arnold, D.M., Crowther, M.A., Cook, R.J., et al. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses. Transfusion 46:8 (2006), 1286–1291.
10. 10 Cook, D., Crowther, M., Meade, M., et al. Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med 33:7 (2005), 1565–1571.
11. 11 Goel, R., Ness, P.M., Takemoto, C.M., Krishnamurti, L., King, K.E., Tobian, A.A., Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality. Blood 125:9 (2015), 1470–1476.
12. 12 Spiess, B.D., Royston, D., Levy, J.H., et al. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 44:8 (2004), 1143–1148.
13. 13 de Boer, M.T., Christensen, M.C., Asmussen, M., et al. The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg 106:1 (2008), 32–44 table of contents.
14. 14 Stephan, F., Montblanc, J., Cheffi, A., Bonnet, F., Thrombocytopenia in critically ill surgical patients: a case-control study evaluating attributable mortality and transfusion requirements. Crit Care 3:6 (1999), 151–158.
15. 15 Dellinger, R.P., Levy, M.M., Rhodes, A., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:2 (2013), 580–637.
16. 16 British Committee for Standards in Haematology BTTF. Guidelines for the use of platelet transfusions. Br J Haematol 122:1 (2003), 10–23.
17. 17 Kaufman, R.M., Djulbegovic, B., Gernsheimer, T., et al. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med 162:3 (2015), 205–213.
18. 18 Eikelboom, J.W., Cook, R.J., Liu, Y., Heddle, N.M., Duration of red cell storage before transfusion and in-hospital mortality. Am Heart J 159:5 (2010), 737–743.e731.
19. 19 Rao, M.P., Boralessa, H., Morgan, C., et al. Blood component use in critically ill patients. Anaesthesia 57:6 (2002), 530–534.
20. 20 Qureshi, H., Lowe, D., Dobson, P., et al. National comparative audit of the use of platelet transfusions in the UK. Transfus Clin Biol 14:6 (2007), 509–513.
21. 21 Kestin, A.S., Valeri, C.R., Khuri, S.F., et al. The platelet function defect of cardiopulmonary bypass. Blood 82:1 (1993), 107–117.
22. 22 Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris, V.A., Ferraris, S.P., Saha, S.P., et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 83:5 suppl (2007), S27–S86.
23. 23 Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris, V.A., Brown, J.R., Despotis, G.J., et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 91:3 (2011), 944–982.
24. 24 Stanworth, S.J., Estcourt, L.J., Powter, G., et al. A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med 368:19 (2013), 1771–1780.
25. 25 Wandt, H., Schaefer-Eckart, K., Wendelin, K., et al. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study. Lancet 380:9850 (2012), 1309–1316.
26. 26 Harding, S.A., Shakoor, M.A., Grindon, A.J., Platelet support for cardiopulmonary bypass surgery. J Thorac Cardiovasc Surg 70:2 (1975), 350–353.
27. 27 Simon, T.L., Akl, B.F., Murphy, W., Controlled trial of routine administration of platelet concentrates in cardiopulmonary bypass surgery. Ann Thorac Surg 37:5 (1984), 359–364.
28. 28 Bilgin, Y.M., van de Watering, L.M., Versteegh, M.I., van Oers, M.H., Vamvakas, E.C., Brand, A., Postoperative complications associated with transfusion of platelets and plasma in cardiac surgery. Transfusion 51:12 (2011), 2603–2610.
29. 29 McGrath, T., Koch, C.G., Xu, M., et al. Platelet transfusion in cardiac surgery does not confer increased risk for adverse morbid outcomes. Ann Thorac Surg 86:2 (2008), 543–553.
30. 30 Karkouti, K., Wijeysundera, D.N., Yau, T.M., et al. Platelet transfusions are not associated with increased morbidity or mortality in cardiac surgery. Can J Anaesth 53:3 (2006), 279–287.
31. 31 Bolliger, D., Tanaka, K.A., Roles of thrombelastography and thromboelastometry for patient blood management in cardiac surgery. Transfus Med Rev 27:4 (2013), 213–220.
32. 32 Avidan, M.S., Alcock, E.L., Da Fonseca, J., et al. Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth 92:2 (2004), 178–186.
33. 33 Weber, C.F., Gorlinger, K., Meininger, D., et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 117:3 (2012), 531–547.
34. 34 Halpern, S.D., Becker, D., Curtis, J.R., et al. An official American Thoracic Society/American Association of Critical-Care Nurses/American College of Chest Physicians/Society of Critical Care Medicine policy statement: the Choosing Wisely(R) Top 5 list in Critical Care Medicine. Am J Respir Crit Care Med 190:7 (2014), 818–826.
35. 35 Shaz, B.H., Dente, C.J., Nicholas, J., et al. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion 50:2 (2010), 493–500.
36. 36 Inaba, K., Lustenberger, T., Rhee, P., et al. The impact of platelet transfusion in massively transfused trauma patients. J Am Coll Surg 211:5 (2010), 573–579.
37. 37 Holcomb, J.B., Wade, C.E., Michalek, J.E., et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 248:3 (2008), 447–458.
38. 38 Holcomb, J.B., Tilley, B.C., Baraniuk, S., et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 313:5 (2015), 471–482.
39. 39 Kumar, A., Mhaskar, R., Grossman, B.J., et al. Platelet transfusion: a systematic review of the clinical evidence. Transfusion 55:5 (2015), 1116–1127.
40. 40 Batchelor, J.S., Grayson, A., A meta-analysis to determine the effect on survival of platelet transfusions in patients with either spontaneous or traumatic antiplatelet medication-associated intracranial haemorrhage. BMJ Open, 2(2), 2012, e000588.
41. 41 Khan, H., Belsher, J., Yilmaz, M., et al. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest 131:5 (2007), 1308–1314.
42. 42 Bishop, J.F., Matthews, J.P., McGrath, K., Yuen, K., Wolf, M.M., Szer, J., Factors influencing 20-hour increments after platelet transfusion. Transfusion 31:5 (1991), 392–396.
43. 43 Stanworth, S.J., Navarrete, C., Estcourt, L., Marsh, J., Platelet refractoriness—practical approaches and ongoing dilemmas in patient management. Br J Haematol 171:3 (2015), 297–305.
44. 44 Hod, E., Schwartz, J., Platelet transfusion refractoriness. Br J Haematol 142:3 (2008), 348–360.
45. 45 Thomas, L., Kaidomar, S., Kerob-Bauchet, B., et al. Prospective observational study of low thresholds for platelet transfusion in adult dengue patients. Transfusion 49:7 (2009), 1400–1411.
46. 46 Kerkhoffs, J.L., Eikenboom, J.C., van de Watering, L.M., van Wordragen-Vlaswinkel, R.J., Wijermans, P.W., Brand, A., The clinical impact of platelet refractoriness: correlation with bleeding and survival. Transfusion 48:9 (2008), 1959–1965.
47. 47 Nijsten, M.W., ten Duis, H.J., Zijlstra, J.G., et al. Blunted rise in platelet count in critically ill patients is associated with worse outcome. Crit Care Med 28:12 (2000), 3843–3846.
48. 48 Vanderschueren, S., De Weerdt, A., Malbrain, M., et al. Thrombocytopenia and prognosis in intensive care. Crit Care Med 28:6 (2000), 1871–1876.
49. 49 Meehan, K.R., Matias, C.O., Rathore, S.S., et al. Platelet transfusions: utilization and associated costs in a tertiary care hospital. Am J Hematol 64:4 (2000), 251–256.
50. 50 Slichter, S.J., Davis, K., Enright, H., et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 105:10 (2005), 4106–4114.
51. 51 Bishop, J.F., McGrath, K., Wolf, M.M., et al. Clinical factors influencing the efficacy of pooled platelet transfusions. Blood 71:2 (1988), 383–387.
52. 52 Bock, M., Muggenthaler, K.H., Schmidt, U., Heim, M.U., Influence of antibiotics on posttransfusion platelet increment. Transfusion 36:11-12 (1996), 952–954.
53. 53 Alcorta, I., Pereira, A., Ordinas, A., Clinical and laboratory factors associated with platelet transfusion refractoriness: a case-control study. Br J Haematol 93:1 (1996), 220–224.
54. 54 Pavenski, K., Warkentin, T.E., Shen, H., Liu, Y., Heddle, N.M., Posttransfusion platelet count increments after ABO-compatible versus ABO-incompatible platelet transfusions in noncancer patients: an observational study. Transfusion 50:7 (2010), 1552–1560.
55. 55 Heddle, N.M., Cook, R.J., Webert, K.E., et al., Biomedical Excellence for Safer Transfusion Working Party of the International Society for Blood Transfusion. Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies. Transfusion 43:6 (2003), 742–752.
56. 56 Arnold, D.M., Lauzier, F., Rabbat, C., et al. Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness. Thromb Res 131:3 (2013), 204–209.